Advisers vote on whether FDA should authorize Pfizer COVID vaccine for kids
A panel of Food and Drug Administration advisors voted on whether the agency should authorize Pfizer's COVID-19 vaccine for children ages 5-11.
Medical Treatments
Decades after polio, Martha is among the last to still rely on an iron lung to breathe
Martha Lillard had just turned 5 years old when polio incapacitated her. She still uses a form of the ventilator that saved her life as a child — though now she worries about replacement parts.
U.S. COVID infection rates have been dropping, but that could change
Many COVID-19 trendlines are headed in a positive direction in the U.S., but there are lots of unknowns about what will happen this winter as vaccinations still lag behind many other countries.
Puerto Rico is the most vaccinated place in the U.S.
NPR's Audie Cornish speaks with Mónica Feliú-Mójer of Ciencia Puerto Rico on how grassroots organizing and responsible messaging helped Puerto Rico achieve the highest U.S. COVID vaccination rate.
Moderna says new data supports its COVID vaccine for kids 6 to 11
Moderna says a study in kids 6 to 11 found two doses of the company's COVID-19 vaccine given 28 days apart produced a strong antibody response.
Pfizer says its COVID-19 is over 90% effective in kids ages 5-11
Pfizer-BioNTech says their COVID-19 vaccine is 90% effective in kids ages 5 to 11. The Food and Drug Administration is likely to decide on emergency authorization as soon as the last week of October.
CDC advisers vote to recommend Moderna and Johnson & Johnson boosters
An advisory panel to the Centers for Disease Control and Prevention has backed the rollout of boosters for the Moderna and Johnson & Johnson vaccines.
India marks its 1 billionth COVID vaccination — but the fight is far from over
India is celebrating its 1 billionth COVID-19 vaccination. But only a third of its population is fully-inoculated, and export orders are backed up.
The FDA authorizes Moderna and J&J COVID vaccine boosters
The Food and Drug Administration also gave an OK to boosters that differ from the vaccine originally used to immunize people against COVID-19. A mix-and-match approach could ease the booster rollout.
FDA authorizes Moderna and Johnson & Johnson boosters and 'mix and match' approach
The Food and Drug Administration has authorized booster shots for the Moderna and Johnson & Johnson COVID-19 vaccines. It's also allowing "mixing and matching" of vaccines as boosters.